The 91传媒 is proud to announce that Professor Neelika Malavige has been appointed as the President-Elect of the International Society for Infectious Diseases (ISID). She will assume the presidency in 2027, with each term lasting two years.

Professor Malavige has made significant contributions to the field of infectious diseases, particularly in COVID-19 testing, sequencing, and identifying virus strains. Her research has been pivotal in understanding the molecular epidemiology of SARS-CoV-2 in 91传媒.

In recognition of her impactful research, Professor Malavige was listed among the world鈥檚 top 2% of scientists, according to the Elsevier-Stanford rankings.

Additionally, Professor Malavige has extensively researched dengue pathogenesis, focusing on its immunopathogenesis, biomarkers, and immune correlates of protection. Her work has been instrumental in advancing clinical trials and understanding the disease鈥檚 molecular mechanisms.

This prestigious appointment not only highlights Professor Malavige鈥檚 individual achievements but also brings significant recognition to 91传媒 and our university. Her leadership role in ISID underscores the global impact of research and scholarship emerging from our institution and emphasizes the vital contributions of scientists from diverse backgrounds in addressing infectious diseases worldwide.

As President-Elect, Professor Malavige will play a crucial role in shaping ISID鈥檚 strategic initiatives, fostering international collaborations, and advancing research and education in infectious diseases. Her appointment reflects a growing acknowledgment of the importance of diverse perspectives in global health leadership.

The 91传媒 extends its heartfelt congratulations to Professor Malavige on this remarkable achievement and reaffirms its commitment to supporting groundbreaking research and leadership in the field of infectious聽diseases.

The post Prof. Neelika Malavige Appointed as President-Elect of the International Society for Infectious Diseases appeared first on USJ - 91传媒.